The US has placed J&J (Johnson and Johnson) in charge of one plant that botched 15mn shots of its coronavirus vaccine and stopped drug manufacturer AstraZeneca from utilizing the facility, said a health official on Saturday.
In a statement, J&J said that it was bearing full responsibility of Baltimore’s Emergent BioSolutions facility, claiming that it would deliver 100mn shots of the vaccine to government by May end.
The Health and Services Department facilitated this move, said the senior health official, asking to keep his identity concealed considering the sensitivity of this situation.
AstraZeneca, who coronavirus vaccine hasn’t received a green signal in the US yet, said that it would work with the Biden admin to look for an alternative location to manufacture its vaccine.
On the other hand, the department also hampers the efforts of AstraZeneca in the US. The government so far has criticized the company for utilizing out-dated information in the final results of it vaccine trial. AstraZeneca later on revised its research.
The Emergent BioSolutions workers conflated the ingredients for AstraZeneca and J&J vaccines many weeks ago, said the Times previously this week. However, J&J said that the botched batch hadn’t advanced towards the finish stage.
The government’s decision to allow the facility to develop just single-shot J&J vaccine is mainly to prevent future mix-ups, said Times.